However, unlike in the chronic phase of the human disease, BCR-ABL expression in transgenic CML is artificial: BCR-ABL is overexpressed—often from multiple BCR-ABL copies and active promoters located outside of the endogenous Bcr locus. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.